KORU Medical Systems, Inc. is projected to rise to $5.04 by 2027, a +21% move from its current price of $4.15. KRMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.05 | $4.15 | $4.26 | +0.04% |
| May 30 | $4.01 | $4.15 | $4.31 | +0.08% |
| May 31 | $3.98 | $4.15 | $4.34 | +0.12% |
| Jun 1 | $3.95 | $4.16 | $4.37 | +0.16% |
| Jun 2 | $3.93 | $4.16 | $4.40 | +0.20% |
| Jun 3 | $3.91 | $4.16 | $4.43 | +0.24% |
| Jun 4 | $3.89 | $4.16 | $4.45 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.89 | $4.16 | $4.45 | +0.27% |
| Week 2 | $3.79 | $4.17 | $4.59 | +0.55% |
| Week 3 | $3.72 | $4.18 | $4.70 | +0.83% |
| Week 4 | $3.67 | $4.20 | $4.80 | +1.10% |
| Week 5 | $3.62 | $4.21 | $4.89 | +1.38% |
| Week 6 | $3.58 | $4.22 | $4.98 | +1.66% |
| Week 7 | $3.54 | $4.23 | $5.06 | +1.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
KORU Medical Systems, Inc. is a healthcare company that develops, manufactures, and commercializes subcutaneous infusion solutions for the subcutaneous drug delivery market in the United States and internationally. The FREEDOM infusion systems are used to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), CIDP, SIDD, and PNH.
Its product lineup includes the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing.
The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
KRMD is a healthcare stock positioned in the subcutaneous infusion market, with a current price of $4.10 and a market cap of $188.33M. It ranks 3876 by market cap in the broader market space. The stock’s near-term technical picture shows neutral to cautious positioning as it trades around multi-period averages.
The near-term technical picture features a 50-day simple moving average of $4.17 and a 200-day simple moving average of $4.58, with a defined support at $3.83 and a resistance at $4.44. The 30-day price range spans from $3.44 to $4.88, reflecting modest volatility and a neutral sentiment in the immediate term.
A major floor 14.9% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 37.3% above — clearing it would confirm fresh momentum.
Key KRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.12 | Buy | $4.11 | Buy |
| MA 10 | $4.01 | Buy | $4.07 | Buy |
| MA 20 | $4.04 | Buy | $4.07 | Buy |
| MA 50 | $4.16 | Sell | $4.21 | Sell |
| MA 100 | $4.63 | Sell | $4.40 | Sell |
| MA 200 | $4.58 | Sell | $4.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.12 | Neutral |
| Stoch RSI (14) | 62.26 | Neutral |
| CCI (20) | 68.74 | Neutral |
| Williams %R (14) | -47.54 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -1.19 | Sell |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 52.46 | Neutral |
| TRIX (15) | -0.19 | Sell |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 63.57 | Neutral |
| Momentum (10) | 0.15 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 4.21 | Sell |
| ADX (14) | 11.54 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day range is $3.44 to $4.88, underscoring a modest trading band around the current level. The RSI14 sits at 50, and the sentiment is NEUTRAL. The stock is trading near the SMA50 of $4.17, with the SMA200 at $4.58 providing a longer-term context.
Support is indicated at $3.83 and resistance at $4.44, offering a defined risk/reward framework for traders monitoring the next moves within the 30-day window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.83 | $4.15 | $6.00 | 0% | Neutral | |
| $4.02 | $5.04 | $6.68 | +21% | Bullish | |
| $4.25 | $5.46 | $7.48 | +32% | Bullish | |
| $4.45 | $5.84 | $8.22 | +41% | Bullish | |
| $4.19 | $5.60 | $8.06 | +35% | Bullish | |
| $4.83 | $6.56 | $9.63 | +58% | Bullish | |
| $5.86 | $8.10 | $12.10 | +95% | Bullish | |
| $6.12 | $8.58 | $13.02 | +107% | Bullish | |
| $6.38 | $9.07 | $13.98 | +119% | Bullish | |
| $6.44 | $9.28 | $14.50 | +124% | Bullish | |
| $9.29 | $14.23 | $23.57 | +243% | Bullish | |
| $14.95 | $25.43 | $45.89 | +513% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.83 | $4.15 | $4.89 | +0.00% |
| June 2026 | $3.60 | $4.22 | $5.06 | +1.74% |
| July 2026 | $3.64 | $4.30 | $5.22 | +1.87% |
| August 2026 | $3.80 | $4.51 | $5.54 | +4.97% |
| September 2026 | $3.85 | $4.60 | $5.69 | +1.91% |
| October 2026 | $3.78 | $4.54 | $5.65 | -1.33% |
| November 2026 | $3.82 | $4.61 | $5.77 | +1.51% |
| December 2026 | $3.93 | $4.76 | $6.00 | +3.35% |
Click any year to see its month-by-month KRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The KRMD price prediction for 2026 points to an average of $4.15 (low $3.83, high $6.00) — a potential gain of 0% on today's $4.15. A consolidation phase looks the most probable path here.
In 2027, KRMD is projected to trade between $4.02 and $6.68, averaging $5.04 — a potential gain of +21% from today's $4.15. That is up +21% on the projected 2026 average. Momentum favours further upside here.
KORU Medical Systems, Inc.'s 2028 outlook centres on $5.46, within a $4.25 to $7.48 range. That is up +8% on the projected 2027 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, KRMD could reach as high as $8.22, with a base case around $5.84 and support toward $4.45 — roughly +41% from $4.15. Momentum favours further upside here.
Expect KRMD to range from $4.19 to $8.06 through 2030. The $5.60 average target implies a +35% move from current prices. That is -4% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The KRMD price prediction for 2031 points to an average of $6.56 (low $4.83, high $9.63) — a potential gain of +58% on today's $4.15. Momentum favours further upside here.
In 2032, KRMD is projected to trade between $5.86 and $12.10, averaging $8.10 — a potential gain of +95% from today's $4.15. That is up +23% on the projected 2031 average. Buyers look set to stay in control over this stretch.
KORU Medical Systems, Inc.'s 2033 outlook centres on $8.58, within a $6.12 to $13.02 range. That is up +6% on the projected 2032 average. That marks a +107% change versus current levels. Momentum favours further upside here.
By 2034, KRMD could reach as high as $13.98, with a base case around $9.07 and support toward $6.38 — roughly +119% from $4.15. Buyers look set to stay in control over this stretch.
Expect KRMD to range from $6.44 to $14.50 through 2035. The $9.28 average target implies a +124% move from current prices. That is up +2% on the projected 2034 average. Momentum favours further upside here.
The KRMD price prediction for 2040 points to an average of $14.23 (low $9.29, high $23.57) — a potential gain of +243% on today's $4.15. Buyers look set to stay in control over this stretch.
In 2050, KRMD is projected to trade between $14.95 and $45.89, averaging $25.43 — a potential gain of +513% from today's $4.15. That is up +79% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in KRMD today (≈ 240.963855 KRMD) could be worth
$6,127.76
+$5,127.76 (+513%) by 2050 · US Dollar
Based on the average projected KRMD price of $25.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRMDwould be worth at today's price.
$1,000 invested in KRMD on May 27, 2025 (≈ 343.642602 KRMD) would be worth
$1,426.12
+$426.12 (+42.6%) today · 1.43× · US Dollar
Based on a KRMD entry price of $2.91 vs. today's $4.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4 | $1,037.5 | +3.8% |
| 1 month ago | $4.06 | $1,022.17 | +2.2% |
| 3 months ago | $4.95 | $838.38 | -16.2% |
| 6 months ago | $5.92 | $701.01 | -29.9% |
| 1 year ago | $2.91 | $1,426.12 | +42.6% |
| All time (5.0y) ago | $4.67 | $888.65 | -11.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRMD forecast.
Our base-case forecast reaches $8.30 around 2033.
Implied market cap at $8.30: $381.24M
The year-by-year forecast shows a path of gradual to strong upside over time. In 2026 the avg is $4.10 with a min of $3.83 and a max of $5.98, and a neutral sentiment for that year. From 2027 onward, the outlook turns bullish with rising averages and solid ROIs: 2027 avg $4.97 (ROI 21.1%), 2028 avg $5.38 (ROI 31.3%), 2029 avg $5.72 (ROI 39.4%), and 2030 avg $5.41 (ROI 32%).
The forecast continues to widen the upside, with 2031 avg $6.40 (ROI 56.2%), 2032 avg $7.90 (ROI 92.6%), 2033 avg $8.28 (ROI 101.9%), 2034 avg $8.83 (ROI 115.4%), and 2035 avg $8.98 (ROI 119.1%).
Longer term, 2040 shows a substantial leap to an avg of $13.78 with a max of $23.10 and ROI of 236, while 2050 projects a dramatic ascent to an avg of $24.24 with a max of $44.39 and ROI of 491.2. The numbers illustrate a bullish trajectory across the later years, though these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 is forecast to have an avg price of $5.41 with a min of $4.02 and a max of $7.85, and a projected ROI of 32%. The sentiment for 2030 is BULLISH.
The forecast shows bullish sentiment from 2027 onward, with increasing averages and ROIs: 2027 avg $4.97 (ROI 21.1%), 2028 avg $5.38 (ROI 31.3%), 2029 avg $5.72 (ROI 39.4%), 2030 avg $5.41 (ROI 32%), 2031 avg $6.40 (ROI 56.2%), 2032 avg $7.90 (ROI 92.6%), 2033 avg $8.28 (ROI 101.9%), 2034 avg $8.83 (ROI 115.4%), 2035 avg $8.98 (ROI 119.1%), 2040 avg $13.78 (ROI 236%), and 2050 avg $24.24 (ROI 491.2%). The figures indicate upside potential, but they are estimates and not guarantees.
Yes. The forecast max rises above $10 in several years, with 2032 max $11.91 and 2033 max $12.69, showing potential for KRMD to exceed $10 in the forecast horizon.
Current price is $4.10 and market cap is $188.33M.
The 30-day price range is $3.44 to $4.88.
KORU Medical Systems, Inc. Community Discussion
0Share your KORU Medical Systems, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.